《Table 1 Biomarkers predicting≥F3 fibrosis in Japanese non-alcoholic fatty liver disease patients》

《Table 1 Biomarkers predicting≥F3 fibrosis in Japanese non-alcoholic fatty liver disease patients》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《"Current status, problems, and perspectives of non-alcoholic fatty liver disease research"》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
AUC:Area under the receiver operating characteristic curve.

Novel agents under clinical trials:Several promising agents undergoing clinical trials are listed in Table 3.Among them，obeticholic acid，elafibranor，selonsertib，and cenicriviroc are now in phase III trials[83].It is noteworthy that these trials evaluate not only histological improvement of NASH，but also the benefit of long-term outcome for NASH patients，such as prevention of progression into cirrhosis，hepatic decompensation，and death.

图表编号XD0049331500    严禁用于非法目的
绘制时间2019.01.14
作者Naoki Tanaka、Takefumi Kimura、Naoyuki Fujimori、Tadanobu Nagaya、Michiharu Komatsu、Eiji Tanaka
绘制单位Department of Metabolic Regulation, Shinshu University School of Medicine、International Research Center for Agricultural Food Industry, Shinshu University、Department of Internal Medicine, Shinshu University School of Medicine、Department of Internal Medici
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1.The current status of coupled models and coupled assimilation in world modeling and prediction centers applied i》2018.07.16
  2. 《Table 3 Updated evaluation of curability after endoscopic submucosal dissection in Japanese gastric cancer treatment gui》2019.04.14
  3. 《Table 2 Updated preoperative indications for endoscopic submucosal dissection in Japanese gastric cancer treatment guide》2019.04.14
  4. 《Table 2 Role of immune components in predicting disease severity》2019.03.31
  5. 《Table 2 Representative indices predicting≥F3 fibrosis in non-alcoholic fatty liver disease patients》2019.01.14
  6. 《Table 1 Predictive factors for complete pathological response in univariate logistic regression analysis for all patient》2019.01.07
  7. 《Table 11 Predictive factors for complete pathological response in multivariate logistic regression analysis for the mFOL》2019.01.07
  8. 《Table 10 Predictive factors for complete pathological response in univariate logistic regression analysis for the mFOLFO》2019.01.07
  9. 《Table 10 Predictive factors for complete pathological response in univariate logistic regression analysis for the mFOLFO》2019.01.07
  10. 《Table 2 Predictive factors for complete pathological response in multivariate logistic regression analysis for all patie》2019.01.07
  11. 《Table 2 Data structure in neural prediction model》2019.01.20
  12. 《Table 1 Identification of plasma biomarkers in HCMV hepatitis cases》2019.01.15
  13. 《Table 2 Identification of urine biomarkers in HCMV infection cases》2019.01.15
  14. 《表2 两组肝纤维化比较分析 (n=66, ±s) Table 2 Comparative analysis of liver fibrosis in two groups (n=66, ±s)》2018.09.14
  15. 《表2 水稻籽粒Cd含量预测模型1) Table 2 Models predicting the Cd content in rice grains》2018.04.15
  16. 《表2 大鼠肝硬化形成过程中纤维化程度评分比较_ (±s, n=4, 单位:分) Table 2 Comparison of fibrosis scores in cirrhosis rats (±s, n=4, unit:score)》2018.07.10
  17. 《表2 治疗前后血清骨代谢指标比较[M (P25, P75) ]Table 2 Comparison of serum bone turnover biomarkers in women before and after treatment[》2018.07.10
  18. 《Table 2Comparison of functional liver levels and liver fibrosis parameters in serum.》2018.10.15
  19. 《表5 2015-2016年不同时段产量预报模型外推预报Table 5 Extrapolation prediction of yield prediction models in different periods during 2015-》2018.05.20
  20. 《表6 不同预警时间下伤亡人数Table 6 Casualties prediction in different warning time》2018.06.01

随机翻阅

《表1 引种试验材料表：观赏贝母在北京地区的引种观察》 《表2 不同汇率制度下的财政乘数研究》 《表1 电子束辐照完成产品微生物检测结》 《表1 整车基本参数：基于Cruise的纯电动汽车的参数匹配与仿真》 《表4:两组患者治疗期间的安全性比较[n(%)]》 《表1 AMZI光波导结构参数》 《表1 0 艇体计算结果汇总》 《表2 读数误差实验：一种玻璃管液位计除垢器的应用》 《表2 航迹起始结果比较Table 2 The comparison of track initiation results》 《表4 PExprt建模参数Tab.4 PExprt modeling parameters》